bf/NASDAQ:AVXL_icon.jpeg

NASDAQ:AVXL

Anavex Life Sciences Corp.

  • Stock

USD

Last Close

4.50

17/05 20:00

Market Cap

511.70M

Beta: 0.75

Volume Today

942.30K

Avg: 1.09M

PE Ratio

−8.31

PFCF: −16.52

Sep '13
Sep '14
Sep '15
Sep '16
Sep '17
Sep '18
Sep '19
Sep '20
Sep '21
Sep '22
Sep '23
net income
-3.70M
-
-11.37M
207.25%
-12.11M
6.51%
-14.74M
21.71%
-13.46M
8.66%
-17.45M
29.66%
-26.29M
50.66%
-26.28M
0.06%
-37.91M
44.25%
-47.98M
26.56%
-47.51M
0.99%
depreciation and amortization
576
-
768
33.33%
995
29.56%
1.25K
25.83%
deferred income tax
475.39K
-
5.56M
1,070.61%
482.16K
91.34%
-58.14K
112.06%
stock based compensation
1.00M
-
637.92K
36.37%
1.63M
156.14%
5.06M
209.81%
4.14M
18.31%
5.52M
33.40%
6.43M
16.56%
4.88M
24.16%
8.23M
68.78%
18.38M
123.28%
16.37M
10.93%
change in working capital
465.91K
-
-336.25K
172.17%
1.24M
468.08%
640.07K
48.29%
382.81K
40.19%
-646.00K
268.75%
1.30M
301.49%
116.52K
91.05%
-706.44K
706.30%
5.36M
858.85%
2.50M
53.27%
accounts receivables
-772.39K
-
-2.21M
185.68%
-4.29M
94.30%
5.94M
238.64%
484K
91.86%
inventory
772.39K
-
2.21M
185.68%
4.29M
94.30%
-5.94M
238.64%
-484K
91.86%
accounts payables
976.88K
-
-151.40M
-
683.80K
-
465.72K
31.89%
750.73K
61.20%
-915.00K
221.88%
497K
154.32%
other working capital
-510.97K
-
-336.25K
34.19%
1.24M
468.08%
152.04M
12,184.36%
382.81K
99.75%
-646.00K
268.75%
617.82K
195.64%
-349.20K
156.52%
-1.46M
317.28%
6.28M
530.69%
2.01M
68.00%
other non cash items
978.10K
-
2.84M
190.52%
4.53M
59.29%
-145.57K
103.22%
-75.20K
48.34%
35.38K
-
845K
-
net cash provided by operating activities
-777.57K
-
-2.66M
242.01%
-4.23M
58.95%
-9.24M
118.52%
-9.02M
2.38%
-12.58M
39.54%
-18.53M
47.25%
-21.29M
14.90%
-30.38M
42.73%
-24.24M
20.23%
-27.79M
14.63%
investments in property plant and equipment
-3.02K
-
acquisitions net
purchases of investments
sales maturities of investments
other investing activites
net cash used for investing activites
-3.02K
-
debt repayment
-88.14K
-
-34.76K
60.57%
common stock issued
801.28K
-
368.17K
54.05%
12.34M
3,252.80%
3.17M
74.34%
27.27M
760.97%
8.17M
70.03%
17.83M
118.16%
28.75M
61.25%
153.22M
432.86%
20.98M
86.30%
27.88M
32.84%
common stock repurchased
dividends paid
other financing activites
310K
-
9.21M
2,871.38%
-101.13K
-
-50K
50.56%
-403.76K
707.53%
23.64K
105.85%
303.31K
1,183.10%
1.78M
485.53%
net cash used provided by financing activities
1.11M
-
9.58M
762.02%
12.26M
27.94%
3.13M
74.44%
27.27M
770.53%
8.07M
70.40%
17.78M
120.27%
28.35M
59.43%
153.24M
440.53%
21.29M
86.11%
29.65M
39.29%
effect of forex changes on cash
net change in cash
333.71K
-
6.92M
1,972.76%
8.03M
16.07%
-6.10M
176.03%
18.25M
399.03%
-4.51M
124.71%
-745.01K
83.48%
7.06M
1,048.10%
122.86M
1,639.37%
-2.95M
102.40%
1.87M
163.26%
cash at beginning of period
11.36K
-
345.07K
2,937.09%
7.26M
2,004.52%
15.29M
110.56%
9.19M
39.92%
27.44M
198.69%
22.93M
16.43%
22.19M
3.25%
29.25M
31.84%
152.11M
420.04%
149.16M
1.94%
cash at end of period
345.07K
-
7.26M
2,004.52%
15.29M
110.56%
9.19M
39.92%
27.44M
198.69%
22.93M
16.43%
22.19M
3.25%
29.25M
31.84%
152.11M
420.04%
149.16M
1.94%
151.02M
1.25%
operating cash flow
-777.57K
-
-2.66M
242.01%
-4.23M
58.95%
-9.24M
118.52%
-9.02M
2.38%
-12.58M
39.54%
-18.53M
47.25%
-21.29M
14.90%
-30.38M
42.73%
-24.24M
20.23%
-27.79M
14.63%
capital expenditure
-3.02K
-
free cash flow
-777.57K
-
-2.66M
242.40%
-4.23M
58.77%
-9.24M
118.52%
-9.02M
2.38%
-12.58M
39.54%
-18.53M
47.25%
-21.29M
14.90%
-30.38M
42.73%
-24.24M
20.23%
-27.79M
14.63%

All numbers in USD (except ratios and percentages)